All three models agree that TSLA is primed for a mean-reversion bounce over the next 1-3 weeks, citing a bullish MACD zero-line crossover on the 4h timeframe and RSI rising from oversold territory. Analysts highlight critical support holding at $297.38, with a projected relief rally targeting the $333-337 resistance zone and potentially $369.01 if the SMA20 is reclaimed. This upside is supported by a confirmed bullish market regime, sector confirmation from the XLY, and potential short covering of the 35.6% short volume.
All three models characterize the current price action as a low-volume 'dead-cat bounce' within a structural downtrend, noting that TSLA remains below key 4h and daily moving averages following a -38.9% earnings miss. Bears emphasize a 'nosebleed' 278x P/E ratio and collapsing 3.7% margins, suggesting the rally will fail at the $327-337 resistance shelf due to lack of institutional conviction. One model specifically warns that the upcoming US PCE event could trigger a rejection, leading to a retest of the $297 support or lower as the stock continues to underperform the broader market.
TSLA is stretched at support near its 52-week low ($314 vs $297.38 daily support, +5.6%) with daily RSI at 33 rising and a fresh 4h MACD bullish zero-cross, signaling an oversold mean-reversion bounce within a bullish equity regime. The expected path is a relief rally toward the $337 daily resistance over 1-3 weeks as momentum repairs and short covering (35.6% short volume) unwinds. Aligned bullish regime and XLY sector confirmation support upside participation into the bounce.
TSLA remains deeply broken on the daily chart — price is -37% from the 52-week high, trading below SMA 20/50 on both daily and 4h, with a horrific -38.9% Q2 earnings miss and a nosebleed 278x trailing P/E on collapsing 3.7% margins. The near-term bounce off $297 support is a weak, low-volume relief rally into overhead supply; a rejection below the $327-337 resistance shelf and 30-min exhaustion (RSI 64, above upper band) should resume the downtrend toward a retest of the $297-300 support zone over the next 1-3 weeks.
TSLA is retesting the $297-310 support zone near its 52-week low after a prolonged selloff, with clear momentum divergence forming on the 4h timeframe — RSI rising from oversold territory and a bullish MACD zero-line crossover. The stock has been rejected from the $337 resistance but is now consolidating above the $310 near-term support with improving short-term momentum (30m RSI 64.6, price above both 30m SMAs). With the broader market in a confirmed bullish regime and Consumer Discretionary (XLY) confirming the move, a mean-reversion bounce toward the 1day resistance at $337 and potentially the 4h SMA20 at $333 is the expected path over 1-3 weeks.
TSLA is in a structural downtrend after a -38.9% earnings miss on Jul 21, trading below all key moving averages on both the 4h and daily timeframes. The current bounce from $297 support is occurring on depressed volume (12th percentile) and lacks institutional conviction, making it a dead-cat bounce that will fail at the $330-337 resistance zone (4h SMA20 and 1d resistance confluence). With a P/E of 278x and no fresh catalyst to reverse the post-earnings breakdown, the path of least resistance remains lower, and a failed retest of resistance will re-establish the downtrend toward the $297 support and potentially lower.
TSLA is showing signs of a potential reversal from oversold conditions, with a bullish MACD crossover on the 4-hour chart and rising RSI, suggesting momentum is shifting in favor of buyers. The stock is currently trading near a critical support level at $297.38, which has held firm in recent sessions, and a confirmed reclaim of the $332.88 SMA20 could act as a catalyst for a move toward the $369.01 resistance level. The broader bullish regime and sector confirmation from XLY further support the case for a swing-long trade, particularly if TSLA can sustain its current momentum and break through near-term resistance.
TSLA is positioned for a short swing trade due to its technical breakdown and weak participation in the broader market rally. The stock is trading below key moving averages (SMA20 and SMA50 on both 4h and daily timeframes) , with RSI rising but still in bearish territory (33.23 on 4h) , suggesting weak momentum. The recent bullish MACD crossover is not confirmed by higher-timeframe structure or volume, and price is extended into resistance at $369.01, making a rejection likely. The regime is bullish but narrow, with TSLA under performing its sector (XLY +0.70% vs TSLA +1.67%) , and the upcoming US PCE event could act as a catalyst for profit-taking or rotation out of overbought mega-cap stocks.